Product Information
CHLORPROMAZINE 200 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.6636 per EA under NDC 62332073931. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on Jul 18, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332073931
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLORPROMAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217350FDA Approved
7/18/2023
TE Code
AB
On Market Since
7/20/2023
Pharmacological Classes
Price Statistics
The NADAC for CHLORPROMAZINE 200 MG TABLET has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6636 per EA |
|---|---|
| All-time high | $2.2720 (Feb 14, 2024) |
| All-time low | $0.6419 (Apr 22, 2026) |
| 52-week high | $1.2885 |
| 52-week low | $0.6419 |
| Median price | $1.2386 |
| Average price | $1.1160 |
| Largest weekly change | +42.8% (Jun 19, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Chlorpromazine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorpromazine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORPROMAZINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLORPROMAZINE 200 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.6636 per EA (NDC 62332073931), effective Sep 30, 2026.
How has the price of CHLORPROMAZINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLORPROMAZINE 200 MG TABLET has declined 70.8%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for CHLORPROMAZINE 200 MG TABLET?
Since Feb 14, 2024, the NADAC for CHLORPROMAZINE 200 MG TABLET has ranged from a low of $0.6419 (Apr 22, 2026) to a high of $2.2720 (Feb 14, 2024), with a median of $1.2386 per EA.
Are there cheaper alternatives to CHLORPROMAZINE 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CHLORPROMAZINE 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORPROMAZINE 200 MG TABLET?
CHLORPROMAZINE 200 MG TABLET (NDC 62332073931) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.